Pranav Garimella, MBBS, MPH

home / authors / pranav-garimella-mbbs-mph

Pranav Garimella, MBBS, MPH, is chief medical officer of the American Kidney Fund.

Articles

3d render of a packaged set of semaglutide injection pens

Insight: Pharmacists Play Key Role in Educating Patients With CKD on Semaglutide Use, Management

Luke Halpern, Assistant Editor;Pranav Garimella, MBBS, MPH
February 25th 2025

According to Pranav Garimella, pharmacists are essential in counseling patients with CKD on the appropriate use of semaglutide.

Read More

Expert: Approval of Semaglutide Major Advancement for CKD, Cardiovascular Risk Reduction in Type 2 Diabetes

Expert: Approval of Semaglutide Major Advancement for CKD, Cardiovascular Risk Reduction in Type 2 Diabetes

Luke Halpern, Assistant Editor;Pranav Garimella, MBBS, MPH
February 20th 2025

Semaglutide has been approved for reducing kidney disease progression and cardiovascular risk in patients with type 2 diabetes, marking a significant advancement in CKD management.

Read More

Latest Updated Articles

Benjamin Franklin on US dollar surrounded by pills | Image Credit: © Cagkan - stock.adobe.com
Published: January 22nd 2025 | Updated: January 28th 2025
Reversal of Executive Order 14087 Raises Questions About Future Drug Pricing Reforms
A pregnant woman sits on a bed, holding a glass of water in one hand while preparing to take prenatal vitamins in the other. She appears thoughtful and focused on her health - Image credit: Prostock-studio | stock.adobe.com
Published: December 18th 2024 | Updated: January 2nd 2025
Study Shows Choline and Iodine Are Missing Links in Prenatal Supplements
Sweden - March 23, 2015: McDonald's yellow and red logo advertising sign placed on a pole with against clear blue sky
Published: October 23rd 2024 | Updated: October 24th 2024
What to Know About E Coli Outbreak Linked to McDonald’s Quarter Pounders
10 Pharmacy Quotes That Will Make You Rethink the Profession
Published: January 18th 2016 | Updated: October 18th 2024
10 Pharmacy Quotes That Will Make You Rethink the Profession
Gabapentin Differs From Pregabalin in Several Key Ways
Published: September 22nd 2015 | Updated: October 14th 2024
Gabapentin Differs From Pregabalin in Several Key Ways
Expert: Abelacimab Shows Significant Bleeding Reduction, Offering Safer Option for Atrial Fibrillation Treatment
Published: February 5th 2025 | Updated: February 25th 2025
Expert: Abelacimab Shows Significant Bleeding Reduction, Offering Safer Option for Atrial Fibrillation Treatment